Sfoglia per Rivista DERMATOLOGY
Dermoscopy of a plantar combined blue nevus: A simulator of melanoma
2007-01-01 Panasiti, V; Devirgiliis, V; Mancini, M; Rossi, M; Curzio, M; Mastrecchia, B; Bottoni, U; Innocenzi, D; Calvieri, S; Borroni, Rg
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis
2020-01-01 Chiricozzi, Andrea; Esposito, Maria; Gisondi, Paolo; Valenti, Mario; Gori, Niccolò; Giovanardi, Giulia; Bellinato, Francesco; De Simone, Clara; Costanzo, Antonio; Fargnoli, Maria Concetta; Peris, Ketty
Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival
2018-01-01 Costanzo, A; Malara, G; Pelucchi, C; Fatiga, F; Barbera, G; Franchi, A; Galeone, C
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers
2009-01-01 Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy
2009-01-01 Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S
Griscelli syndrome type 2: long-term follow-up after unrelated donor bone marrow transplantation
2009-01-01 Rossi, A; Carrozzo, Am; de Felice, C; Menichelli, A; Carlesimo, M; Calvieri, S; Borroni, Rg
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis
2016-01-01 Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab
2010-01-01 Papoutsaki, M; Talamonti, M; Giunta, A; Costanzo, A; Ruzzetti, M; Teoli, M; Chimenti, S.
Marked Reduction of the Number and Individual Volume of Sebaceous Glands in Psoriatic Lesions
2016-01-01 Liakou, Ai; Nyengaard, Jr; Bonovas, S; Knolle, J; Makrantonaki, E; Zouboulis, Cc
Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension.
2011-01-01 Talamonti, M; Teoli, M; Botti, E; Spallone, G; Chimenti, S; Costanzo, A
Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy
2002-01-01 Brazzelli, V; Prestinari, F; Chiesa, Mg; Ardigò, M; Borroni, G; Borroni, Rg
What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice
2014-01-01 Talamonti, M; Galluzzo, M; Bianchi, L; Boca, An; Costanzo, A; Chimenti, S
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Dermoscopy of a plantar combined blue nevus: A simulator of melanoma | 1-gen-2007 | Panasiti, V; Devirgiliis, V; Mancini, M; Rossi, M; Curzio, M; Mastrecchia, B; Bottoni, U; Innocenzi, D; Calvieri, S; Borroni, Rg | |
| Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis | 1-gen-2020 | Chiricozzi, Andrea; Esposito, Maria; Gisondi, Paolo; Valenti, Mario; Gori, Niccolò; Giovanardi, Giulia; Bellinato, Francesco; De Simone, Clara; Costanzo, Antonio; Fargnoli, Maria Concetta; Peris, Ketty | |
| Effectiveness End Points in Real-World Studies on Biological Therapies in Psoriasis: Systematic Review with Focus on Drug Survival | 1-gen-2018 | Costanzo, A; Malara, G; Pelucchi, C; Fatiga, F; Barbera, G; Franchi, A; Galeone, C | |
| Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers | 1-gen-2009 | Costanzo, A; Talamonti, M; Botti, E; Spallone, G; Papoutsaki, M; Chimenti, S | |
| Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy | 1-gen-2009 | Costanzo, A; Talamonti, M; Spallone, G; Botti, E; Chimenti, Ms; Papoutsaki, M; Chimenti, S | |
| Griscelli syndrome type 2: long-term follow-up after unrelated donor bone marrow transplantation | 1-gen-2009 | Rossi, A; Carrozzo, Am; de Felice, C; Menichelli, A; Carlesimo, M; Calvieri, S; Borroni, Rg | |
| IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis | 1-gen-2016 | Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A | |
| The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab | 1-gen-2010 | Papoutsaki, M; Talamonti, M; Giunta, A; Costanzo, A; Ruzzetti, M; Teoli, M; Chimenti, S. | |
| Marked Reduction of the Number and Individual Volume of Sebaceous Glands in Psoriatic Lesions | 1-gen-2016 | Liakou, Ai; Nyengaard, Jr; Bonovas, S; Knolle, J; Makrantonaki, E; Zouboulis, Cc | |
| Patients with moderate to severe plaque psoriasis: one year after the European Medicines Agency recommendation of efalizumab suspension. | 1-gen-2011 | Talamonti, M; Teoli, M; Botti, E; Spallone, G; Chimenti, S; Costanzo, A | |
| Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy | 1-gen-2002 | Brazzelli, V; Prestinari, F; Chiesa, Mg; Ardigò, M; Borroni, G; Borroni, Rg | |
| What happened after the clinical trials: long-term safety and efficacy of ustekinumab in daily clinical practice | 1-gen-2014 | Talamonti, M; Galluzzo, M; Bianchi, L; Boca, An; Costanzo, A; Chimenti, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile